Cardiac Sarcoidosis
📧 Sign up to get email alerts when something new happens for Cardiac Sarcoidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Repurposing Tilmanocept for Cardiac Sarcoidosis [Phase 2]
Duke University is conducting a Phase 2 clinical trial to repurpose tilmanocept (Lymphoseek) for cardiac sarcoidosis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis [Phase 2]
Phase 2 clinical trial evaluating interleukin-1 blockade for cardiac sarcoidosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis [Phase 2]
A Phase 2 study evaluating namilumab in active cardiac sarcoidosis was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Routine Cardiac Screening in Sarcoidosis Patients
This ClinicalTrials.gov update notes the completion of a study sponsored by the Foundation for Sarcoidosis Research evaluating routine cardi…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis [NA]
A completed clinical trial evaluating somatostatin receptor imaging in patients with acute myocarditis and cardiac sarcoidosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: PET/MR Imaging In Patients With Cardiac Sarcoidosis [NA]
This clinical trial update notes that the PET/MR imaging study in patients with cardiac sarcoidosis has been completed. The update does not …
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis [Phase 2]
Phase 2 clinical trial update for 68GaNOTA-Anti-MMR-VHH2 imaging agent across multiple indications including solid malignancies of the head …
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation [Phase 2]
Phase 2 clinical trial evaluating 18F-FSPG PET/MRI or PET/CT imaging for cardiac sarcoidosis and myocardial inflammation; study terminated w…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis [Phase 4]
A Phase 4 clinical trial evaluating d68Ga-DOTATATE PET/CT for assessing cardiac sarcoidosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Non-Invasive Characterization in Cardiac Sarcoidosis [NA]
A terminated clinical trial exploring non-invasive characterization in cardiac sarcoidosis; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: DEtection of Cellular Inflammation With FERumoxytol in the HEART [Phase 2, Phase 3]
The clinical trial update confirms completion of Phase 2 and Phase 3 studies evaluating ferumoxytol-enhanced imaging to detect cellular infl…
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET
A completed study comparing FDG PET versus Ga-DOTANOC PET imaging in cardiac sarcoidosis was reported in this ClinicalTrials.gov update.